학술논문
A phase 1 study in healthy volunteers to investigate the safety, tolerability, and pharmacokinetics of VIR-2482: a monoclonal antibody for the prevention of severe influenza A illness
Document Type
Article
Author
Source
In: Antimicrobial Agents and Chemotherapy . (Antimicrobial Agents and Chemotherapy, April 2024, 68(4))
Subject
Language
English
ISSN
10986596
00664804
00664804